MGP Ingredients (MGPI) Q4 2025 earnings summary

Executive summary

• 2025 results exceeded guidance despite a challenging spirits industry, with progress on strategic initiatives and operational improvements, though a significant non-cash impairment in Branded Spirits drove reported net losses.

• Organizational changes and new leadership hires were implemented to align with strategic priorities and drive disciplined execution.

• Focus on premium plus brands, portfolio rationalization, and digital marketing supported long-term value creation.

Financial highlights

• Full-year 2025 consolidated sales declined 24% to $536.4 million; Q4 sales down 23% to $138.3 million.

• Adjusted EBITDA for 2025 was $116.0 million (down 41%); adjusted basic EPS was $2.85 (down 49%).

• Net income for 2025 was a loss of $107.8 million, mainly due to a $152.6 million non-cash impairment in Branded Spirits.

• Operating cash flow reached a record $121.5 million, up 19% year-over-year; CapEx was $31.9 million, down over 50%.

• Net debt leverage ratio was 2.0x at year-end 2025; total debt $252 million.

Outlook and guidance

• 2026 net sales expected at $480–$500 million, Adjusted EBITDA at $90–$98 million, and Adjusted EPS at $1.50–$1.80; effective tax rate projected at 27%.

• Branded Spirits sales expected to decline mid-single digits; Distilling Solutions sales and gross profit expected down 35% and 40%, respectively.

• Ingredient Solutions segment projected to recover with sales of $140–$150 million and gross margin in the mid to high teens.

• CapEx for 2026 expected at $20 million; Penelope earnout payment of $111 million in Q2 and refinancing of $201 million convertible notes in Q4.

• Net debt leverage to peak at 3.75x in Q2 2026, with plans to delever post-Penelope payment.